Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2012 Sep;64(9):1328–1333. doi: 10.1002/acr.21691

Table 1.

Subject Characteristics Stratified by Cognitive Function

Cognitive function
All patients
(n=694)
Unimpaired
(n=587)
Impaired
(n=107)
P
Age, yrs 50.0±12.9 50.3±12.6 48.4±14.5 0.061
Female, n (%) 640 (92.2) 542 (92.3) 98 (91.6) 0.791
Education, n (%)
 high-school or less 114 (16.4) 77 (13.1) 37 (34.6) 0.000
 some college 282 (40.6) 230 (39.2) 52 (48.6)
 college graduate 173 (24.9) 160 (27.3) 13 (12.1)
 post-graduate (ref.) 125 (18) 120 (20.4) 5 (4.7)
Below poverty, n (%) 96 (13.8) 64 (10.9) 32 (29.9) 0.000
Depression, n (%) 129 (18.6) 79 (13.5) 50 (46.7) 0.000
Disease Activity (SLAQ) 11.4±7.8 10.6±7.4 15.6±8.7 0.025
Disease Duration, yrs 17.1±8.6 17.4±8.6 15.7±8.5 0.866
Antiphospholipid
antibodies, n (%)
274 (39.5) 217 (37) 57 (53.3) 0.002
Hypertension, n (%) 401 (57.8) 325 (55.4) 76 (71) 0.003
Hyperlipidemia, n (%) 276 (39.8) 233 (39.7) 43 (40.2) 0.924
Diabetes, n (%) 77 (11.1) 59 (10.1) 18 (16.8) 0.040
Obese, n (%) 189 (27.2) 153 (26.1) 36 (33.6) 0.105
Current smoking, n (%) 61 (8.8) 43 (7.3) 18 (16.8) 0.001
Myocardial Infarction,
n (%)
46 (6.6) 37 (6.3) 9 (8.4) 0.420
Stroke, n (%) 71 (10.2) 50 (8.5) 21 (19.6) 0.000

All variables are self-reported with the exception of presence of antiphospholipid antibodies and disease duration which were collected from chart review. SLAQ = Systemic Lupus Activity Questionnaire.